Scientists analyse structure of antibodies that could be key to more effective cancer treatments
Scientists at the Centre for Cancer Immunology have gained unprecedented new insight into the key properties of an antibody needed to fight off cancer.
New clinical trial targets rare and often incurable cancer
Researchers at the Centre for Cancer Immunology are applying an immunotherapy treatment to an often-incurable form of cancer in a new clinical trial opening in Southampton.
Southampton scientists reveal a new fundamental feature of resistance to therapy in aggressive chronic lymphocytic leukaemia
Research led by the Centre for Cancer Immunology could help identify patients at risk of rapid progression and resistance to therapy in chronic lymphocytic leukaemia (CLL).
Study highlights ongoing risk of COVID-19 in some cancer patients despite vaccination
New study highlights the importance of COVID-19 vaccination boosters for cancer patients.
Centre study reveals “crown-like structures” in breast tumours could hinder treatment
‘Crown-like structures’ surrounding breast tumours in overweight and obese patients could hinder their response to therapy, a new Southampton study has found.
Take a virtual tour of the Southampton Clinical Trials Unit for International Clinical Trials Day
To celebrate International Clinical Trials Day today (20th May) the Southampton Clinical Trials Unit (SCTU) has launched a virtual tour of their offices in the Centre for Cancer Immunology (CCI).
Professor Sally Ward becomes Fellow of the Royal Society
A pioneer of cancer research at the Centre for Cancer Immunology has been named a Fellow of the Royal Society.
Oxygen starvation makes tumours more resistant to antibody treatment
A lack of oxygen (hypoxia) makes tumours more resistant to antibody treatments, according to a new study by scientists at the Centre for Cancer Immunology.
Third COVID-19 vaccination improves immune response in blood cancer patients
Dr Sean Lim, based at the Centre for Cancer Immunology, has led new research that shows the weakened immune systems of blood cancer patients can improve after they receive a third COVID-19 vaccination.
New insight into how antibodies bind to the immune system
Centre research, published in Communications Biology, describes the factors which control the ability of antibodies targeting CD27 to stimulate the immune system.